are oral contraceptive drugs that have been the subject of recent lawsuits because of their link to an increased risk of blood clots. They are one of the fourth generation drugs for prevention of pregnancy. They are the first drugs to use drospirenone, a synthetic progestin. Yaz contains 3mg of drospirenone and 0.02 mg of ethinyl estradiol per tablet, where as Yasmin contains 3 mg of drospirenone and 0.03 mg of ethinyl estradiol per tablet. Generic versions of these drugs are also available in the market. The manufacturer of these drugs Bayer pharmaceutical have faced the wrath of the Food